CD4 and neoplasm: To enable additional characterization, we curated markers for tumor‐reactive T cells from two studies.[17, 18] Using these markers, we scored the tumor‐reactive T cells within the TLS (Figure 4G) and found that mTLS had the highest tumor‐reactive scores for CD4 and CD8 T cells, while nTLS had the lowest.